Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus

Alicia J Jenkins; Albina K Gosmanova; Timothy J Lyons; Kerri D May; Azar Dashti; Mary Z Baker; Leann Olansky; Chris E Aston; George L Dale

doi:10.1016/j.diabres.2008.04.004

Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus

Alicia J Jenkins, Albina K Gosmanova, Timothy J Lyons, Kerri D May, Azar Dashti, Mary Z Baker, Leann Olansky, Chris E Aston, George L Dale

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

Abstract

Coated-platelet levels were quantified in 58 people with Type 1 diabetes, 90 with Type 2 diabetes, and 54 non-diabetic controls. In diabetes high coated-platelet levels were related to smoking and glucose control drugs, but not to glycaemia or other drugs. Prospective studies should evaluate coated-platelets and complications and drug effects.

Original language	English
Pages (from-to)	e8-10
Journal	Diabetes Research and Clinical Practice
Volume	81
Issue number	2
DOIs	https://doi.org/10.1016/j.diabres.2008.04.004
Publication status	Published - Aug 2008

Keywords

Adolescent
Adult
Blood Platelets
Collagen
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Humans
Middle Aged
Platelet Count
Thrombin

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.diabres.2008.04.004

Cite this

@article{af221a0fc3ee446a91709516ff2d8132,

title = "Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus",

abstract = "Coated-platelet levels were quantified in 58 people with Type 1 diabetes, 90 with Type 2 diabetes, and 54 non-diabetic controls. In diabetes high coated-platelet levels were related to smoking and glucose control drugs, but not to glycaemia or other drugs. Prospective studies should evaluate coated-platelets and complications and drug effects.",

keywords = "Adolescent, Adult, Blood Platelets, Collagen, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Middle Aged, Platelet Count, Thrombin",

author = "Jenkins, {Alicia J} and Gosmanova, {Albina K} and Lyons, {Timothy J} and May, {Kerri D} and Azar Dashti and Baker, {Mary Z} and Leann Olansky and Aston, {Chris E} and Dale, {George L}",

year = "2008",

month = aug,

doi = "10.1016/j.diabres.2008.04.004",

language = "English",

volume = "81",

pages = "e8--10",

journal = "Diabetes Research and Clinical Practice",

issn = "1872-8227",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

TY - JOUR

T1 - Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus

AU - Jenkins, Alicia J

AU - Gosmanova, Albina K

AU - Lyons, Timothy J

AU - May, Kerri D

AU - Dashti, Azar

AU - Baker, Mary Z

AU - Olansky, Leann

AU - Aston, Chris E

AU - Dale, George L

PY - 2008/8

Y1 - 2008/8

N2 - Coated-platelet levels were quantified in 58 people with Type 1 diabetes, 90 with Type 2 diabetes, and 54 non-diabetic controls. In diabetes high coated-platelet levels were related to smoking and glucose control drugs, but not to glycaemia or other drugs. Prospective studies should evaluate coated-platelets and complications and drug effects.

AB - Coated-platelet levels were quantified in 58 people with Type 1 diabetes, 90 with Type 2 diabetes, and 54 non-diabetic controls. In diabetes high coated-platelet levels were related to smoking and glucose control drugs, but not to glycaemia or other drugs. Prospective studies should evaluate coated-platelets and complications and drug effects.

KW - Adolescent

KW - Adult

KW - Blood Platelets

KW - Collagen

KW - Diabetes Mellitus, Type 1

KW - Diabetes Mellitus, Type 2

KW - Humans

KW - Middle Aged

KW - Platelet Count

KW - Thrombin

U2 - 10.1016/j.diabres.2008.04.004

DO - 10.1016/j.diabres.2008.04.004

M3 - Article

C2 - 18508150

SN - 1872-8227

VL - 81

SP - e8-10

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

IS - 2

ER -

Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this